Ekso Bionics Holdings Inc
(EKSO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 2,897 | 2,264 | 1,468 | 3,720 | 3,319 |
| Cost of Goods | 1,084 | 1,005 | 831 | 1,865 | 1,569 |
| Gross Profit | 1,813 | 1,259 | 637 | 1,855 | 1,750 |
| Operating Expenses | 4,318 | 4,356 | 6,249 | 5,559 | 6,109 |
| Operating Income | -2,421 | -3,092 | -4,781 | -2,839 | -3,790 |
| Interest Expense | 23 | 38 | 52 | 68 | 88 |
| Other Income | 4,896 | -8,637 | 2,299 | 186 | 4,084 |
| Pre-tax Income | 2,452 | -11,767 | -2,534 | -2,721 | 206 |
| Net Income Continuous | 2,452 | -11,767 | -2,534 | -2,721 | 206 |
| Net Income | $2,452 | $-11,767 | $-2,534 | $-2,721 | $206 |
| EPS Basic Total Ops | 4.50 | -28.19 | -6.60 | -6.15 | 0.60 |
| EPS Basic Continuous Ops | 4.46 | -28.18 | -6.55 | -6.17 | 0.62 |
| EPS Diluted Total Ops | -0.15 | -28.19 | -6.60 | -6.15 | 0.60 |
| EPS Diluted Continuous Ops | 4.39 | -28.18 | -6.55 | -6.17 | 0.62 |
| EBITDA(a) | $-2,110 | $-2,926 | $-4,604 | $-2,660 | $-3,763 |